2018 KSID指南：成人社区获得性肺炎抗生素治疗.pdfVIP

American Thoracic Society Guidelines for the Management of Adults with Community-acquired Pneumonia Diagnosis, Assessment of Severity, Antimicrobial Therapy, and Prevention THIS OFFICIAL STATEMENT OF THE AMERICAN THORACIC SOCIETY WAS APPROVED BY THE ATS BOARD OF DIRECTORS MARCH 9, 2001 EXECUTIVE SUMMARY For all patients with CAP, pneumococcus is the most com- mon pathogen, and may even account for pneumonia in pa- This document is an update of the original 1993 statement on tients who have no pathogen identified by routine diagnostic community-acquired pneumonia, incorporating new informa- testing. Although the incidence of DRSP is increasing, available tion about bacteriology, patient stratification, diagnostic evalu- data show that mortality in CAP is adversely affected by drug- ation, antibiotic therapy, and prevention. The statement includes resistant pneumococci only when minimal inhibitory concen- a summary of the available literature, as well as evidence-based tration (MIC) values to penicillin are 4 mg/L. The impact of recommendations for patient management, developed by a organisms at lower levels of resistance remains uncertain. All multidisciplinary group composed of pulmonary, critical care,